UMediC集团 获准转主板

UMediC集团 获准转主板

  (吉隆坡3日讯)UMediC集团(UMC,0256,创业板医疗保健组)获得证券监督委员会批准转至主板上市。   艾芬黄氏投资银行代表UMediC集团董事部宣布,已在周三(3日)收到证监会发出的信函。   证监会根据2007年资金市场服务法令,批准了UMediC集团的上市提议以及将产生的股权结构。   在2021年10月上市的UMediC集团,是在去年底宣布将申请转至主板。该集团旗下有7家子公司。  ...
UMediC获证监会批准转至主板上市

UMediC获证监会批准转至主板上市

(吉隆坡3日讯)UMediC Group Bhd获得大马证券监督委员会(SC)批准,转至大马交易所主板上市。   艾芬黄氏投资银行今日代表UMediC宣布上述消息,指证监会批准了转板上市和由此产生的股权结构。这符合2007年资本市场和服务法令第214(1)条文及上市公司的土著股权要求。   该集团于2022年7月26日在创业板上市。     该集团在截至去年7月杪财年(2023财年)净赚1036万令吉,并录得4543万令吉营业额。  ...
UMediC集团 获准转主板

UMediC gets SC’s nod for proposed Main Market transfer

  KUALA LUMPUR (April 3): UMediC Group Bhd has secured approval from the Securities Commission Malaysia (SC) for the proposed transfer to the Main Market of Bursa Malaysia Securities.   Affin Hwang Investment Bank, on behalf of UMediC, announced on Wednesday...
UMediC获证监会批准转至主板上市

UMedic Receives SC Nod For Main Market Transfer

  UMedic Group Berhad announced that the Securities Commission had approved the group’s proposed transfer tp the main market of Bursa. The group was incorporated in 2021 as a private limited company under the name of UMediC Group Sdn Bhd and was subsequently...
UMediC to benefit from government’s focus on healthcare

UMediC to benefit from government’s focus on healthcare

  PETALING JAYA: Despite UMediC Group Bhd (UMC) incurring a surge in operating costs, Hong Leong Investment Bank Research (HLIB Research) is upbeat about the medical device maker’s business going forward. The research house said its optimism remains intact,...